We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

236 hedge funds and large institutions have $860M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 79 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

1% more funds holding

Funds holding: 233236 (+3)

1.02% more ownership

Funds ownership: 46.07%47.09% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

5% less capital invested

Capital invested by funds: $908M → $860M (-$47.4M)

11% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 79

Holders
236
Holders Change
+3
Holders Change %
+1.29%
% of All Funds
4.13%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
70
Reduced
79
Closed
22
Calls
$1.81M
Puts
Net Calls
+$1.81M
Net Calls Change
+$999K
Name Holding Trade Value Shares
Change
Change in
Stake
Cambridge Investment Research Advisors
26
Cambridge Investment Research Advisors
Iowa
$5.12M +$21.2K +124 +0.4%
JMPWA
27
JP Morgan Private Wealth Advisors
California
$4.95M +$658K +3,853 +15%
RIA
28
RPG Investment Advisory
California
$4.78M -$96.9K -567 -2%
PAG
29
Private Advisor Group
New Jersey
$4.77M -$236K -1,379 -5%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$4.72M +$2.8M +16,367 +135%
BFEC
31
Benjamin F. Edwards & Company
Missouri
$3.94M -$112K -658 -3%
KAS
32
Kestra Advisory Services
Texas
$3.76M -$2.43M -14,232 -39%
BRWA
33
B. Riley Wealth Advisors
Florida
$3.59M -$13.8K -81 -0.4%
TRCT
34
Tower Research Capital (TRC)
New York
$3.58M +$1.4M +8,199 +61%
AA
35
Ancora Advisors
Ohio
$3.51M +$3.61M +21,131 New
CA
36
Crumly & Associates
Illinois
$3.11M -$92.8K -543 -3%
MCWS
37
McKinley Carter Wealth Services
West Virginia
$2.84M -$107K -627 -4%
Citigroup
38
Citigroup
New York
$2.74M -$1.45M -8,470 -34%
GIA
39
Gladstone Institutional Advisory
Florida
$2.63M +$87.8K +514 +3%
SWAG
40
Spectrum Wealth Advisory Group
California
$2.63M +$10.9K +64 +0.4%
KPWS
41
Kestra Private Wealth Services
Texas
$2.51M -$35K -205 -1%
UCFA
42
United Capital Financial Advisors
Texas
$2.39M -$62.9K -368 -2%
TC
43
TownSquare Capital
Utah
$2.37M +$369K +2,161 +18%
CHAM
44
Clear Harbor Asset Management
Connecticut
$2.17M +$22.2K +130 +1%
PSF
45
Pacific Sun Financial
California
$2.13M +$2.19M +12,828 New
HAS
46
HBW Advisory Services
California
$2.07M +$2.13M +12,472 New
TFA
47
TPG Financial Advisors
Oregon
$2.07M +$109K +639 +5%
AI
48
Atria Investments
North Carolina
$2.05M +$27.5K +161 +1%
FTUS
49
Flow Traders U.S.
New York
$2.03M -$2.53M -14,783 -55%
IWC
50
Integrated Wealth Concepts
Massachusetts
$2.03M +$12K +70 +0.6%

FBT Hedge Fund Activity: Q3 2021 in Review

236 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2021, worth a combined $860M — down 5.2% from $908M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FBT positions and 22 closed out — a net gain of 6 holders — while 70 added to existing stakes and 79 trimmed.

The largest buyer was Karp Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Morgan Stanley, cutting an estimated $19.2M.

  • 236 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2021, up from 233 in Q2 2021.
  • Funds reported $860M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2021, down 5.2% quarter-over-quarter.
  • 28 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2021 and 22 closed out, a net change of +6 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2021 was Karp Capital Management, an estimated $11.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2021 was Morgan Stanley, an estimated $19.2M sold.

Based on aggregated 13F filings for Q3 2021.